A conversation with the winning team of the Sixth Annual Next Generation for Biosecurity Competition — A Destructive Duality In December of 1942, the first controlled nuclear chain reaction experiment was successfully conducted at the University of Chicago by Enrico Fermi. Less than three years later in July of 1945, the first atomic device was tested in New Mexico as a part of…

A conversation with Citizen Scientist Josh McGinnis — The thing that I love most about science is that it allows you to stand on the precipice of human understanding, and step into the unknown through thoughtful experimentation. But this exhilarating feeling of embracing the uncharted is often still limited to certain environments, and certain people with certain degrees and the experiments normally must have certain conditions. Enter Josh McGinnis, a software engineer turned citizen scientist, whose passion for bioprospecting appeared one day on my LinkedIn feed.

Highlights from the American Society of Gene & Cell Therapy’s 2022 Policy Summit — Cell and gene therapies have the potential to treat and cure some of the most debilitating diseases that humanity faces These therapies could potentially treat and cure diseases like cancer, diabetes, and cystic fibrosis. The FDA has already approved several cellular and gene therapy products including some that focus on the treatment of ß-thalassemia, Spinal Muscular Atrophy (Type I), biallelic RPE65 mutation-associated retinal dystrophy, relapsed or refractory multiple myeloma, and…

We must be bold, and prioritize achieving nutrition security for everyone. —

A Titus Talks Podcast Conversation with Kendra Royston — We are not betting individuals, but if we were, we bet that you have never met an intelligent, humble, creative, and curious individual with the voice of a Madam and whose slogan is “it’s okay to feel stupid, but don’t you dare stay that way.” To conclude Season 2 of Titus Talks, we are delighted to share our conversation with researcher, blogger, podcaster, and author, Kendra Royston.

Accelerating collaboration across the bioeconomy ecosystem by creating a digital talent ecosystem — One of my own personal philosophies is that for science to ever leave the lab and have a tangible impact in the world, business is the vehicle for that change. There are several crucial facets to launching a successful business. Beyond creating value for a target consumer, a founding team needs compelling marketing, operational and delivery excellence, consistent sales, and sound financial management. If scientific founders do not feel like they have the skillsets to tackle all of these elements…

A Titus Talks Podcast Conversation with Anna Puglisi — What do the hallmarks of competing in Wastewater Olympics, playing bass in an orchestra, contributing to a tactical military task force, and becoming an expert in China S&T Policy have in common? Anna has lived them all. Anna Puglisi is the Director of Biotechnology Programs and Senior Fellow at Georgetown’s Center for Security and Emerging Technology (CSET). Previously she served as the National Counterintelligence Officer for East Asia, advising senior U.S. and foreign government officials at the highest levels, academia, and the private sector on counterintelligence (CI)…

A Titus Talks Podcast Conversation with Schuyler Moore — Driving substantive change socially, economically, and politically is grounded in a foundation of national security. Today, we are excited to introduce Schuyler Moore whose passion for women’s education led her to work at an all-girls school in Afghanistan and build a career circling the problem of national security from different perspectives.

A Landscape Analysis of US Federal Investments Across the Bioeconomy — The US Bioeconomy is on track to contribute more than $4 trillion to the global economy over the course of the next decade It is certainly a hope-filled assessment about the potential of the bioeconomy to bring positive, international, economic growth. But in turning our attention to the state of our own nation, the question becomes: